Loading insider details...
Latest Form 4 (Nov 4, 2026): Other (see footnotes) of 21,529 SUPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Supernus, Inc. (SUPN) | Other (see footnotes) | 21,529 | n/a |
| Nov 4, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Other (see footnotes) | 13,979 | n/a |
| Nov 2, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 70,000 | n/a |
| Aug 14, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 750 | n/a |
| Jul 31, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 750 | n/a |
| Feb 26, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,250 | n/a |
| Feb 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,125 | n/a |
| Feb 20, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 13,500 | n/a |
| Sep 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 1,875 | n/a |
| Sep 12, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,875 | n/a |